Search

Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 18 (Search time: 0.006 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)Access
Oxycodonenaloxone.naxolone  versus tapentadol in real world chronic non‑cancer pain.pdf.jpg2022Oxycodone/naloxone versus tapentadol in real‑world chronic non‑cancer pain management: an observational and pharmacogenetic study
Barrachina, Jordi; Margarit, Cesar; Muriel, Javier; López‑Gil, Santiago; López Gil, Vicente; Vara-González, Amaya; Planelles, Beatriz; Inda, María del Mar; Morales, Domingo; Peiró, Ana María
OPRM1 influence on and effectiveness of an individualized.pdf.jpg2018OPRM1 influence on and effectiveness of an individualized treatment plan for prescription opioid use disorder patients
Muriel, Javier; Margarit, César; Planelles, Beatriz; Serralta, María J.; Puga, Carmen; Inda, María del Mar; Cutillas, Esperanza; Morales, Domingo; Horga, José F.
Sex-Differences in Pain and Opioid Use Disorder Management.pdf.jpg2022Sex-Differences in Pain and Opioid Use Disorder Management: A Cross-Sectional Real-World Study
Escorial, Mónica; Muriel, Javier; César, Margarit; Laura, Agulló; Domingo, Morales; Peiró, Ana
Pharmacogenetic Guided Opioid Therapy Improves Chronic.pdf.jpg2023Pharmacogenetic Guided Opioid Therapy Improves Chronic Pain Outcomes and Comorbid Mental Health: A Randomized, Double-Blind, Controlled Study
Agulló, Laura; Aguado, Isidro; Muriel, Javier; Margarit, César; Gómez, Alba; Escorial, Mónica; Sánchez, Astrid; Fernández, Alicia; Peiró, Ana
Clinical prediction of opioid use disorder in chronic pain patients. A cohort-retrospective study with a pharmacogenetic approach.pdf.jpg12-Apr-2024Clinical prediction of opioid use disorder in chronic pain patients: a cohort-retrospective study with a pharmacogenetic approach
Escorial, Mónica; Muriel, Javier; Agulló, Laura; Zandonai, Thomas; Margarit, César; Morales, Domingo; Peiró, Ana
Oxycodonenaloxone - naloxone versus tapentadol in real-world chronic non-cancer pain management.an observational and pharmacogenetic study.pdf.jpgJun-2022Oxycodone/naloxone versus tapentadol in real-world chronic non-cancer pain management: an observational and pharmacogenetic study
Barrachina, Jordi; Margarit, César; Muriel, Javier; López‑Gil, Santiago; López Gil, Vicente; Vara-González, Amaya; Planelles, Beatriz; Inda, María del Mar; Morales, Domingo; Peiró, Ana
Long-term deprescription in chronic pain and opioid use disorder patients. Pharmacogenetic and sex differences.pdf.jpg18-Nov-2022Long-term deprescription in chronic pain and opioid use disorder patients: Pharmacogenetic and sex differences
Muriel, Javier; Escorial, Mónica; Margarit, César; Barrachina, Jordi; Carvajal, Cristian; Morales, Domingo; Peiró, Ana
CYP2D6 Genotype and Pharmacovigilance Impact on Autism Spectrum Disorder. A Naturalistic Study with Extreme Phenotype Analysis.pdf.jpg3-Jul-2023CYP2D6 Genotype and Pharmacovigilance Impact on Autism Spectrum Disorder: A Naturalistic Study with Extreme Phenotype Analysis
Ballester, Purificación; Espadas, Cristina; Almenara, Susana; Barrachina, Jordi; Muriel, Javier; Ramos, Enrique; Toral, Natalia; Belda, César; Peiró, Ana
Impact of CYP2D6 genotype on opioid use disorder deprescription an observational prospective study in chronic pain with sex-differences.pdf.jpg2023Impact of CYP2D6 genotype on opioid use disorder deprescription: an observational prospective study in chronic pain with sex-differences
Muriel, Javier; Barrachina, Jordi; Del Barco, Guillermo; Carvajal, Cristian; Escorial, Mónica; Margarit, César; Ballester, Purificación; Peiró, Ana María
CYP2D6 phenotypes and opioid metabolism. the path to personalised analgesia.pdf.jpgApr-2022CYP2D6 phenotypes and opioid metabolism: the path to personalized analgesiaBallester, Purificación; Muriel, Javier; Peiró, Ana